TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Shandong Weigao Group Medical Polymer Co ( (HK:1066) ) just unveiled an announcement.
Shandong Weigao Group Medical Polymer Company Limited has announced the renewal of its existing continuing connected transactions through Supplemental Agreements with Weigao Holding and its subsidiaries. These agreements involve revising the annual cap for 2025 and extending the terms of the CCT Agreements to 2027. The transactions, which are subject to certain reporting and approval requirements under the Listing Rules, reflect the company’s strategic efforts to maintain and strengthen its business relationships and operational framework.
The most recent analyst rating on (HK:1066) stock is a Hold with a HK$6.50 price target. To see the full list of analyst forecasts on Shandong Weigao Group Medical Polymer Co stock, see the HK:1066 Stock Forecast page.
More about Shandong Weigao Group Medical Polymer Co
Shandong Weigao Group Medical Polymer Company Limited is a joint stock limited company incorporated in the People’s Republic of China. It operates in the medical polymer industry, focusing on the production and distribution of medical devices and supplies.
Average Trading Volume: 17,361,789
Technical Sentiment Signal: Sell
Current Market Cap: HK$25.55B
See more data about 1066 stock on TipRanks’ Stock Analysis page.